Drug Trial Radar · NCT04044690
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)
Last checked: Nov 19, 2026Latest source record: Dec 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
134
Actual
Start
Oct 21, 2019
Primary completion
Dec 2, 2024
Study completion Dec 2, 2024
Sponsor
- Lead sponsor
- CSL BehringIndustry
- Sponsor type
- Industry
- First posted
- Aug 5, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of IgPro20 (subcutaneous Ig) treatment in adult subjects with dermatomyositis (DM). The primary objective of this study is to assess the efficacy of IgPro20 subcutaneous (SC) doses in comparison to placebo in adult subjects with DM, as measured by responder status based on Total Improvement Score (TIS) assessments.
Conditions
- Dermatomyositis
Interventions
human immunoglobulin GDrug
human immunoglobulin G administered subcutaneously
PlaceboDrug
contains 2% human albumin, similar excipients as IgPro20 (Hizentra), same volume, same duration, administered subcutaneously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Responder RateTime frame: At Week 25
Locations
76 sites in 14 countries. Site status is shown where the registry gives one.
8401117 - Arizona Arthritis & Rheumatology Research
Glendale, Arizona
8401199 - Neuromuscular Research Center
Phoenix, Arizona
8401129 - UCLA - Rheumatology Los Angeles
Los Angeles, California
8401473 - RecioMed Clinical Research Network, Inc.
Boynton Beach, Florida
8401160 - Center For Rheumatology
Fort Lauderdale, Florida
8401132 - Omega Research Maitland
Orlando, Florida
8401107 - Morsani Center for Advanced Health Care (CAHC)
Tampa, Florida
8401152 - The University of Kansas Medical Center
Fairway, Kansas
8401476 - DS Research
Louisville, Kentucky
8401487 - Ohio State University
Columbus, Ohio
8401486 - Oregon Health and Science University
Portland, Oregon
8401210 - University of Pennsylvania
Philadelphia, Pennsylvania
8401151 - Biomedical Science Tower
Pittsburgh, Pennsylvania
8401474 - West Tennessee Research Institute, LLC
Jackson, Tennessee
8401115 - The University of Texas Medical School at Houston
Houston, Texas
0320084 - DIM Clinica Privada
Buenos Aires, Argentina
0320081 - Fundacion Respirar
Buenos Aires, Argentina
0320077 - Centro Medico Privado de Reumatolgia
San Miguel de Tucumán, Argentina
0320083 - Hospital Italiano de Buenos Aires
Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina
0560050 - Ghent Universit Hospital (UZ Gent)
Ghent, Belgium
0560048 - Universitair Ziekenhuis (UZ) Leuven
Leuven, Belgium
0560056 - Universitair Ziekenhuis Leuven
Leuven, Belgium
0560049 - CHU de Liège - Sart Tilman
Liège, Belgium
2500146 - CHU De Dijon Hopital Du Bocage
Dijon, France
2500188 - Centre Hospitalier Regional Universitaire de Lille
Lille, France
2500133 - CHU - Hospital de la Timone
Marseille, France
2500135 - CHU Nice-Hopital Archet I
Nice, France
2500132 - Hopital Pitie-Salpetriere
Paris, France
2500144 - Hopitaux Universitaire de Strasbourg
Strasbourg, France
2760203 - Charité
Berlin, Germany
2760211 - Charité - Universitätsmedizin Berlin
Berlin, Germany
2760199 - University Hospital Köln
Cologne, Germany
2760271 - Universitatsklinikum Carl Gustav Carus TU Dresden
Dresden, Germany
2760273 - Hautklinik des Uni-Klinikums Erlangen
Erlangen, Germany
2760036 - University Medicine Göttingen
Göttingen, Germany
2760201 - Medizinische Hochschule Hannover (MHH)
Hanover, Germany
2760210 - University of Münster
Münster, Germany
2760212 - University Hospital Of Tuebingen
Tübingen, Germany
2760268 - University of Ulm
Ulm, Germany
3480048 - University of Debrecen
Debrecen, Hungary
Showing 40 of 76 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.